Marlise R. Luskin, MD, MSCE, discusses the trial of tagraxofusp in BPDCN, which showed high response rates and overall survival.

The addition of brentuximab vedotin to lenalidomide and rituximab extended survival among heavily pretreated patients with ...

Free-speech battles and pressure from Washington threaten America’s oldest university—and the soul of higher education.

A union could address a host of issues, including cost-of-living raises, paid sick time, and a definition of “full-time work” ...

Mass General Brigham, based in Somerville, Mass., is partnering with Philips to enhance real-time patient monitoring by integrating medical device data into a unified platform, a move aimed at ...

Facing a quarter-billion-dollar budget gap over the next two years, Mass General Brigham announced earlier this month that ...

The job cuts will improve efficiency and allow frontline workers more access to leadership, according to the health system.

A new local tech safety program is helping victims of domestic violence protect themselves from their abusers.

Mass General Brigham has announced a collaboration with Regent Surgical (“Regent”) to improve access and reduce costs for patients in New England by creating new MGB ambulatory surgery center ...

A Boston-based foundation is giving $10 million to jumpstart a new program aimed at researching new therapies that can help ...

Investigators from Mass General Brigham have conducted a multi-ancestry, whole genome sequencing association study of Alzheimer's disease and found evidence for 16 new susceptibility genes, expanding ...

Boston-based Mass General Brigham has partnered with ASC management company Regent Surgical. The partnership aims to create access and reduce costs for patients in New England through the creation of ...